As of Oct 02
| -0.17 / -0.94%|
The 2 analysts offering 12-month price forecasts for Osiris Therapeutics Inc have a median target of 26.50, with a high estimate of 28.00 and a low estimate of 25.00. The median estimate represents a +48.54% increase from the last price of 17.84.
The current consensus among 2 polled investment analysts is to Buy stock in Osiris Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.